Skip to main content
PLOS One logoLink to PLOS One
. 2020 Oct 9;15(10):e0239775. doi: 10.1371/journal.pone.0239775

Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria

Destaw Damtie 1,*, Yalemtsehay Mekonnen 2
Editor: Leonidas Matsakas3
PMCID: PMC7546913  PMID: 33036019

Abstract

In this study, we evaluated the antibacterial activities of the essential oils (EOs) of Thymus serrulatus and Thymus schimperi collected from Ofla (Ofl), Alamata (Ala), Yilmana Densa (Yil), Tarmaer (Tar), Butajira (Buta), and Bale (Bal) in Ethiopia against cariogenic bacteria (Streptococcus mutans and Lactobacillus) isolated from human teeth. Inhibition zones (IZs), minimum inhibitory concentrations (MICs), and minimum bactericidal concentrations (MBCs) were measures of the antibacterial activity. Significant bacterial inhibitions resulted in a dose-and EO-dependent manner. At 128 μl/mL, IZs against S. mutans were 37.33 mm (Tar), 36.00 mm (Bal), 33.67 mm (Yil), 33.33 mm (Ofl), 30.00 (Ala), and 29.67 mm (Buta) and IZs against Lactobacillus were 31.00 mm (Tar), 30.67 mm (Yil), 27.67 (Bal), 27.00 (Buta), 26.67 (Ofl), and 21.33 (Ala). The respective inhibition zones due to 3% DMSO (negative control) and 3% H2O2 (positive control) were 0.00 mm/30.00 mm against S. mutans and 0.00 mm/29.00 mm against Lactobacillus. At 128 μl/mL dose, all the EOs resulted in significantly higher inhibition zones than that of 3% H2O2 against S. mutans and Lactobacillus.

Introduction

Dental caries is one of the most prevalent infectious diseases of man [1]. It is a biofilm-mediated, sugar-driven, multifactorial, dynamic disease that results in the phasic demineralization and remineralization of dental hard tissues [2]. Worldwide, approximately 2.43 billion people (36% of the population) had dental caries in their permanent teeth [3]. Reports also show that there is a marked global increase in the prevalence of dental caries [4].

Dental caries is a chronic endogenic multifactorial bacterial infection with gram-positive mutans Streptococci and Lactobacilli long being recognized as the primary cariogenic organisms [5]. Key organisms which cause dental caries include Streptococcus species (S. sanguinis, S. mitis and S. crista), Lactobacillus species (L. gasseri, L. fermentum, and L. salivarius), Fusobacterium, Bacteroides, Porphyromonas, Prevotella, Neisseria, Veillonella, Corynebacterium, Actinomyces, and Treponema species [6].

Oral hygiene, pit and fissure sealing, substituting xylitol for sucrose, vaccines for MS bacteria, oral health management of the primary caregiver of children, and fluoride application are the main methods of caries prevention [7]. However, fluoride applications may lead to elevated levels of fluoride in the body [8].

Owing to cultural and natural reasons, the demand for herbal toothpaste is increasing from time to time. Consequently, the sale of herbal products is exceeding fluoride-based toothpaste [9]. Besides, herbal kinds of toothpaste are reported to be more efficient in the maintenance of oral hygiene and gum bleeding as compared to the non-herbal toothpaste [10].

Furthermore, the growing resistance to classic antimicrobial drugs is a global problem [11]. These are driving forces for the efforts done on the screening of natural products like plant EOs to discover new antimicrobial agents [12]. Many in vitro studies show that the EOs of Achillea ligustica, Baccharis dracunculifolia, Croton cajucara, Cryptomeria japonica, Coriandrum sativum, Eugenia caryophyllata, Lippia sidoides, Ocimum americanum, and Rosmarinus officinalis had promising effects on caries-related streptococci (mainly S. mutans) and lactobacilli [13].

Lamiaceae is one of the most diverse and widespread plant families with antimicrobial properties [14]. In Ethiopia, this family is represented by over 20 genera Thymus and Ocimum being the two most known [15]. The genus Thymus is represented by (T. serrulatus and T. schimperi) both of which are indigenous to Ethiopia [16]. Studies in these species revealed that they have antibacterial activities. The chloroform extract of T. schimperi resulted in inhibition of clinical isolates of human pathogenic bacteria including the Methicillin-Resistant S. aureus (MRSA) [17]. The essential oil of the same species also had marked antibacterial activities [18]. Thyme EOs are known antibacterials [19] against both Gram-positive and Gram-negative bacteria. For example, EO of T. vulgaris was found effective against S. aureus, S. enteritidis, E. coli, and P. aeruginosa [14] and extracts of T.vulgaris against H. pylori and S. mutans [20, 21]. The antibacterial activity of thyme EOs is associated with their different constituents [22]. The effectiveness of the constituents is based on the functional groups they possess and can be ranked as phenols, aldehydes, ketones, alcohols, esters, and hydrocarbons in descending order [23].

The Ethiopian thyme species are known to possess carvacrol and thymol as their major components [16, 24, 25] and are claimed to have antibacterial and antifungal properties [26]. The major chemical constituents of T. serrulatus and T. schimperi in the present study are carvacrol followed by thymol [25]. Thus, the present study was aimed to test the in vitro antibacterial activities of T. serrulatus and T. shimperi EOs against the isolated Streptococci and Lactobacilli.

Materials and methods

Plant material collection and identification

Aerial parts of T. serrulatus and T. shimperi were collected between July and September 2013 Alamata (37p- 0542153N, 1369589E) and Ofla (37p- 0558356N, 1389146E) (Tigray Region), Yilmana Densa (37p- 0325366N, 1228943E) and Tarmaber (37p- 0580250N, 1089386E) (Amhara Region), Butajira (37p -0420973N, 897876E) (Southern Nations Nationalities and Peoples Region), and Dinsho (37p- 0586113N, 785143E) (Bale, Oromia Region). These plants are wild plants which were found in communal lands of the study sites. Besides, these plants are not endangered protected species. Therefore, specific permission was not required for the collection and investigation of the mentioned plants.The Thymus species were identified by Mr. Melaku Wondafrash, a botanist working in the National Herbarium of Addis Ababa University, Addis Ababa, Ethiopia, and voucher specimens were deposited in the Herbarium.

Preparation of plant materials and extraction of essential oils

The collected T. serrulatus and T. schimperi plants were shade dried and milled into powders. The fine powders (200 g) of each plant were added to 2 L distilled water (with vegetal material/ extraction solvent rate = 1/10 (w/v) in a 4 L round bottom glass flask and subjected to water distillation for 3 h using Clevenger type apparatus. Then the volume of each oil was quantified in milliliters (mL), dried over anhydrous sodium sulfate and stored in dark glass at 4°C until used.

Collection of unstimulated whole saliva

Inclusion and exclusion criteria

Students from the biology department of Addis Ababa University were given a full explanation about the purpose of the research. Voluntary students signed letters of consent which were approved by the Research Ethics Review Committee of the College of Natural Sciences of Addis Ababa University. Those students with a DMFT (Decayed, Missing, and Filled Teeth) score of zero were included as subjects to donate saliva. On the other hand, students who were not voluntary to give saliva, those who took antibiotics or corticoids in the last 20 days, who have the habit of smoking, with mucosal inflammatory lesions, and who took orthodontic treatment were excluded. The following method adapted from Navazesh & Kumar [27] was used to collect saliva. The subjects were advised to refrain from intake of any food or beverage one hour before the test session. Smoking, chewing gum, and intake of coffee was also prohibited during this hour. They were advised to rinse their mouth several times with distilled water and then to relax for five minutes. They were then told to swallow to void the mouth of saliva. Then they were told to lean their heads forward over the test tube. They were told to slightly open their mouths and allow saliva to drain into the tubes. At the end of the collection period, they were asked to collect any remaining saliva in their mouths and spit it into the test tubes. Besides, the subjects were asked to brush their teeth using sterile swabs and put them into the test tubes containing their saliva.

Isolation and identification of cariogenic bacteria

Culture method

Saliva was vortex mixed and ten-fold diluted with sterile water before plating. Mitis Salivarius agar (MS agar) supplemented with potassium tellurite and de Man, Rogosa, and Sharpe agar (MRS agar) were used as culture media for isolation of total Streptococci and Lactobacilli respectively. Appropriate amounts of semi-solid media were powered on to Petri-plates and were allowed to solidify at room temperature. To each plate, 100 μL of the diluted sample was spread evenly. The plates were collected and sealed in an anaerobic jar. The anaerobic atmosphere in the anaerobic jar was created using candlelight. Then the plates in the anaerobic jar were incubated at 37°c for 48 hours.

Identification and confirmation of salivary Streptococci and Lactobacilli

To isolate salivary streptococci especially S. mutans, two bacitracin disks that contain 5μl bacitracin were placed 2cm apart on the inoculated agar. Bacterial colonies were observed under a dissecting microscope and deduced based on colony morphology, shape, and color. Furthermore, a confirmation for S. mutans and Lactobacilli was done by Gram staining, catalase tests, arginine dehydrogenase test, and sugar fermentation tests (mannitol, sorbitol, inulin, lactose, raffinose, and melibiose). Aerobic growth was also tested by inserting inverted Durham tubes into test tubes containing broths where the bacteria were inoculated. The presence or absence of air bubbles at the bottom of inverted Durham tubes was considered as an indicator of aerobic or anaerobic respiration respectively [27] “S1S3 Figs”.

Biochemical tests to determine salivary Streptococci and Lactobacilli

These bacteria were allowed to grow in Tryptone Soy Broth containing 0.1% carbohydrates (raffinose, inulin, mannitol, melibiose, lactose, and sorbitol) and 0.5% arginine. Besides, 7.2mL/L of 0.25% phenol red was used as an indicator for the fermentation of the carbohydrates and arginine by the bacteria. The formation of yellow and reddish-pink colors respectively after incubation for 48hrs was considered as positive and negative results of carbohydrate fermentation [28]. On the other hand, the negative and positive fermentation results towards arginine were indicated by the formation of yellow or red and purple colors respectively at the end of 48hrs incubation “S4 Fig”.

Determination of the antibacterial activities of the EOs

Susceptibility tests against S. mutans and Lactobacilli were accomplished using the disk diffusion method on MS agar [29, 30] and MRS agar respectively. The essential oils were diluted in 3% DMSO (DMSO/Distilled water; vol/vol) to the doses of 16 μL/mL, 32 μL/mL, 64 μL/mL, and 128 μL/mL. Paper disks (6 mm diameter) immersed in each dose were allowed to dry at room temperature and placed on Petri-plates inoculated with salivary S. mutans and Lactobacilli. Other disks immersed in 3% DMSO and 3% H2O2 were also used as negative and positive controls respectively.

Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)

The MIC was determined using the agar dilution method which is described by the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases [31]. To determine the MIC, 20mL volumes of agar were used in 9cm Petri dishes for agar dilution. Nineteen mL volumes of each molten agar (MS and MRS agars) were added separately to 1mL volumes of each EO dose to make the total volume 20mL. The overall procedure followed is explained in the next paragraph.

MS and MRS agars prepared as recommended by the manufacturers were set to cool to 50°C in a water-bath. EOs of thyme were prepared into doses of 0.25 μL/mL, 0.5 μL/mL, 1 μL/mL, 2 μL/mL, and 4 μL/mL in 25-30mL containers (five containers for each selective medium). Nineteen mL of molten agars were added to each container and mixed thoroughly, and finally poured into pre-labeled sterile Petri dishes on a level surface. The plates were allowed to dry at room temperature to avoid drops of moisture on the surface of the agar. Bacterial suspensions grown in Tryptic Soy broths supplemented with 0.2% glucose [32, 33] and incubated for 48hrs were inoculated on the dry plates. The inoculum spots were then allowed to dry at room temperature before inverting the plates for incubation. Finally, the plates were incubated at 37°C in anaerobic jars for 48 h. The MIC (the lowest concentration of the extracts that completely inhibited visible growth) was judged by the naked eyes. MBC was determined by taking scratches from MIC tests and trying to grow bacteria on new agar plates. In the case of the growth of colonies from scratches taken from the MIC test plates, the MIC was not considered as MBC and vice-versa.

Statistical analysis

The data were expressed as the mean ± SEM for each group. A computer program (SPSS version 20) was used for statistical analysis. The differences among the groups were performed using one-way analysis of variance (ANOVA) followed by LSD postHoc multiple comparisons. P values < 0.05 were considered statistically significant.

Ethical consideration

This study was conducted after the necessary ethical clearance was obtained from the Ethical Committee of College of Natural Sciences, Addis Ababa University “S1 File”.

Results

Isolation of S. mutans and Lactobacilli

S. mutants and Lactobacillus grew as separate colonies on selective media (MS and MRS) agars respectively. Both isolates produced yellow colors by fermenting the sugars raffinose, mannitol, melibiose, lactose, inulin, and sorbitol. Both isolates were grown in broths supplemented by arginine produced brick red color. They too were catalase-negative and they were unable to generate gas from glucose. The gram stain of the isolates revealed gram-positive spherical chains (Streptococci) and cylindrical cells (Lactobacilli). Furthermore, Streptococcus was found to be resistant to Bacitracin discs (5μl/disc) “S5S18 Figs”. The overall biochemical and physical test results of salivary isolates are presented in Table 1.

Table 1. Biochemical and physical test results against S. mutans and Lactobacillus collected from saliva.

Sugar/Amino Acid fermentation Cat. test Gas from Glu Gram stain Cell shape Bacitracin test
Bacterium Raf Man Mel Lac Arg Inu Sor
Streptococci + + + + - + + - - + Spherical -
Lactobacilli + + + + - + + - - + Cylindrical +

Raf = Raffinose, Man = Mannitol, Mel = Melibiose, Arg = Arginine, Inu = Inulin, Cat = Catalase, Glu = Glucose, (+) = able to ferment or breakdown, gram-positive, bacitracin sensitive, (-) = not able to ferment or break down or do not produce gas from glucose fermentation, gram-negative, resistant to bacitracin.

Antibacterial tests of thyme EOs against S. mutans and Lactobacilli

Antibacterial activity of the EOs against Lactobacillus

The EOs resulted in a dose-dependent inhibition of Lactobacillus of which Tar was the best followed by Yil, Bal, Ofl, Buta, and Ala in decreasing order (Fig 1). The 16 μl/mL dose of these EOs against Lactobacillus resulted in inhibition zones close to 10 mm. Correspondingly, the 32 μl/mL doses except that of Buta and Ala resulted in inhibition zones higher than 10 mm. The trend of increase is also visible at 64 μl/mL doses which resulted in inhibition zones between 10 mm and 20 mm in which Buta was the least close to 10 mm and Tar was the highest close to 20 mm. At the dose of 128 μl/mL, Tar and Yil resulted in inhibition zones higher than that of the positive control (3% H2O2) while Bal and Ofl resulted in inhibition zones closer to this control. However, the inhibition zone recorded by 128 μl/mL EO of Ala was lower than that of the positive control. In the same way, the EOs doses ranging from 16 μl/mL to 128 μl/mL of Ala showed considerable inhibition to this bacterium even though their zones of inhibition were less than that of the 3% H2O2. The negative control (3% DMSO) on the other hand did not inhibit Lactobacillus.

Fig 1. Inhibition of Lactobacillus by EOs from six localities with doses ranging from 16 μl/mL to 128 μl/mL in comparison with the negative and positive controls.

Fig 1

The differences in mean inhibition zones of Lactobacillus are indicated in Table 2. The highest inhibitions of Lactobacillus that resulted from the 128 μl/mL doses of Yil and Tar were significantly higher than similar doses of Ofl, Ala, Buta, Bal EOs, and the positive control (3% H2O2). On the other hand, 3%H2O2 inhibited this bacterium with inhibition zones significantly higher than the 16, 32, and 64 μl/mL doses of all EOs and the 128 μl/mL doses of Ofl, Ala, Buta, and Bal EOs. The inhibition zone of Lactobacillus by the negative control (3% DMSO) was significantly lower than that of all the doses of the EOs and the positive control. Thus the highest and lowest significant mean inhibition zones against Lactobacillus resulted from 128 μl/mL EO of Tar and 16 μl/mL of Buta respectively. Generally, the different doses of Tar and Yil EOs were found to be the strongest EOs against Lactobacillus.

Table 2. Antibacterial activity of the EOs of Ofl, Ala, Yil, Tar, Buta, and Bal using agar disc diffusion method compared to the negative and positive controls (mean ± SEM for three repetitions)*.
Bacteria
S. mutans Lactobacillus
Treatments Concentration Mean ± SEM Mean ± SEM
Controls 3% DMSO 0.00 ± 0.00 o 0.00 ± 0.00 m
3% H2O2 30.00 ± 1.15d 29.00 ± 1.00b
Ofl 16 μl/mL 9.67 ± 0.33m 8.33 ± 0.67kl
32 μl/mL 11.67 ± 0.33l 10.33 ± 0.33ij
64 μl/mL 17.00 ± 0.58ij 12.67 ± 0.33h
128 μl/mL 33.33 ± 0.33c 26.67 ± 0.33c
Ala 16 μl/mL 9.00 ± 0.58mn 8.33 ± 0.33kl
32 μl/mL 12.67 ± 0.67l 9.33 ± 0.33jk
64 μl/mL 22.33 ± 0.33 f 14.33 ± 0.33g
128 μl/mL 30.00 ± 0.58d 21.33 ± 0.33 d
Yil 16 μl/mL 8.00 ± 0.00n 9.33 ± 0.33jk
32 μl/mL 14.33 ± 0.33k 10.67 ± 0.33i
64 μl/mL 25.00 ± 0.00e 18.00 ± 0.00f
128 μl/mL 33.67 ± 0.33c 30.67 ± 0.33a
Tar 16 μl/mL 14.33 ± 0.89k 9.67 ± 0.33ij
32 μl/mL 18.67 ± 0.67h 10.33 ± 0.33ij
64 μl/mL 26.00 ± 1.00 e 19.67 ± 0.88e
128 μl/mL 37.33 ± 0.33a 31.00 ± 0.58a
Buta 16 μl/mL 9.67 ± 0.33m 8.00 ± 0.00l
32 μl/mL 17.67 ± 0.33hi 9.67 ± 0.33ij
64 μl/mL 20.33 ± 0.33g 12.00 ± 0.58 h
128 μl/mL 29.67 ± 0.33d 27.00 ± 0.58c
Bal 16 μl/mL 9.67 ± 0.00m 9.33 ± 0.33jk
32 μl/mL 16.00 ± 0.58j 12.33 ± 0.33h
64 μl/mL 20.00 ± 1.00g 15.00 ± 0.00g
128 μl/mL 36.00 ± 0.58b 27.67 ± 0.33c

Notes: Ofl = Ofla, Ala = Alamata, Yil = Yilmana Densa, Tar = Tarmaer, Buta = Butajira, Bal = Bale, 3% DMSO = negative control-did not show any activity; 3% H2O2 = Positive control, Least significant difference for S. mutans = 1.1861, Least significant difference for Lactobacillus = 1.0757, Means with the same letters in the same column are not significantly different (p>0.05)

* = the strength of activity is presented as resistant (> 7 mm), intermediate (>12 mm) and susceptible (> 18 mm) [34].

Antibacterial activity of the EOs against S. mutans

As can be depicted from Fig 2, S. mutans were inhibited by the different doses of the EOs; Ofl, Ala, Yil, Tar, Buta, and Bal in a dose-dependent manner. This bacterium was inhibited by 3% H2O2 (positive control) and was not inhibited by 3% DMSO (negative control). The smallest range of inhibition of this bacterium was due to the 16 μl/mL concentration of all the EOs which was between 8 and 10 mm. The mean minimum inhibition zones of all the test EOs at the dose of 32 μl/mL lied between 10 and 20 mm Ofl being with the least (11.67 ± 0.33 mm) and Tar with the highest (18.67 ± 0.67) inhibition zones.

Fig 2. Inhibition of S. mutans by EOs from six localities with doses ranging from 16 μl/mL to 128 μl/mL in comparison with the negative and positive controls.

Fig 2

At 64 μl/mL concentration, S. mutans was inhibited with mean inhibition zones better than that resulted due to the 32 μl/mL concentration. At this dose, four of the EOs Ala, Yil, Tar, and Buta resulted in mean inhibition zones between 20 and 30 mm and Tar resulted in the highest mean inhibition zone (26.00 ± 1.00) and Buta the lowest (20.33 ± 0.33). The rest two EOs Ala and Bal, however, resulted in mean inhibition zones lower than 20 mm. At 128 μl/mL concentration of the EOs, S. mutans was highly inhibited by all the EOs. At this dose level, around 67% of the EOs (Ofl, Yil, Tar, and Bal) inhibited S. mutans with inhibition zones higher than that of the positive control. The rest 33% of the EOs (Ala and Buta) inhibited this bacterium with inhibition zones comparable to that of the positive control.

At the dose 128 μl/mL, Tar inhibited S. mutans with inhibition zones significantly higher than the rest EOs and the positive control. It was followed by the 128 μl/mL dose of Bal which in turn was followed by the 128 μl/mL doses of Ofl and Yil. The least inhibition of S. mutans at this dose was seen in Ala and Buta EOs. At 64 μl/mL dose, significant inhibition of S. mutans was as follows: Yil and Tar > Ala >Buta and Bal. At the dose of 32 μl/mL, the order of inhibition of S. mutans was Tar and Buta > (significantly higher than) Ala > Bal > Yil > Ofl. The 16 μl/mL dose of Tar inhibited S. mutans with inhibition zone comparable with the 32 μl/mL of Yil and with significantly higher inhibition zone than the 32 μl/mL of Ala > 16 μl/mL of Ofl, Ala, Buta and Bal > 16 μl/mL of Yil > 3%DMSO.

Thus the Tar (128 μl/mL) and the Yil (16 μl/mL) were found to be the most and the least inhibitor doses of S. mutans. The positive control resulted in inhibition zones higher than the 16, 32, and 64 μl/mL doses of the entire test EOs and the negative control (3% DMSO) resulted in no inhibitions. In general, Tar EO appeared to be the strongest inhibitor of S. mutans than the rest EOs Table 2.

MIC and MBC of EOs against S. mutans and Lactobacillus

The MIC and MBC of the test EOs were determined for both bacteria. The MIC and MBC of S. mutans were found to be 0.25 μl/mL by Bal and 0.5 μl/mL by all the rest EOs Table 3. On the other hand, the MIC and MBC against Lactobacillus were at the dose of 0.5 μl/mL by all the test EOs.

Table 3. Antibacterial activity (MIC and MBC) of Thyme EOs against S. mutans and Lactobacillus.
S. mutans Lactobacillus
Botanical Name Essential Oil MIC* (μl/mL) MBC** (μl/mL) MIC* (μl/mL) MBC** (μl/mL)
Thymus serrulatus Ofl 0.5 0.5 0.5 0.5
Thymus serrulatus Ala 0.5 0.5 0.5 0.5
Thymus serrulatus Yil 0.5 0.5 0.5 0.5
Thymus schimperi Tar 0.5 0.5 0.5 0.5
Thymus schimperi Buta 0.5 0.5 0.5 0.5
Thymus schimperi Bal 0.25 0.25 0.5 0.5

Notes: Ofl = Ofla, Ala = Alamata, Yil = Yilmana Densa, Tar = Tarmaer, Buta = Butajira, Bal = Bale

*MIC = Highest dilution (minimum concentration) showing no detectable growth

**MBC = Highest dilution (minimum concentration) yielded no single colony on a solid medium.

Discussion

According to different findings, oxygenated monoterpenes like thymol and carvacrol exhibit strong antimicrobial activity and hydrocarbon derivatives possess lower antimicrobial properties. This is because the low water solubility of hydrocarbons limits their diffusion through the medium. For example, in the work by Sokovic et al. [35], the trend of antibacterial activity of EO components were as; linalyl acetate < limonene < β-pinene < α-pinene < camphor < linalool < 1,8-cineole < menthol < thymol < carvacrol against Proteus mirabilis (human isolate) Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (ATCC 12228), Micrococcus flavus (ATCC 9341), Bacillus subtilis (ATCC 10707), Escherichia coli (ATCC 0157:H7), Enterobacter cloacae (human isolate), Salmonella enteritidis (ATCC 13076), Salmonella typhimurium (ATCC 13311).

The EOs of thyme in the present study contained components with high antibacterial activities (thymol and carvacrol) [36]. The respective percentages of thymol and carvacrol in the test EOs were as follows: Ofl (49.55%, 36.34%), Ala (65.63%, 6.68%), Yil (6.52%, 80.84%), Tar (48.84%, 42.12%), Buta (15.77%, 71.83%), and Bal (53.57%, 34.55%) [25]. Therefore, it is possible to infer from this finding that the EOs of Yil, Buta, and Tar showed the highest antibacterial activity against S. mutans and Lactobacillus followed by that of Bal, Ofl, and Ala respectively. However, minor deviations were seen in the recorded results.

Tar EO showed the highest inhibition of both S. mutans and Lactobacillus. This may be due to the synergistic/additive activities of thymol and carvacrol components [37] since the two are found in close percentages 48.84% and 42.12%, respectively and the sum of the two is the highest of all the EOs. On the other hand, the least effective was the EO from Ala since it is majorly of thymol (65.63%) and less of carvacrol (6.68%) composition [35].

In the work by Barkat and Bouguerra [38], the inhibition zones of thymol and carvacrol against S. mutans were 7.8 mm and 8.0 mm, respectively at 50 mg/mL dose each. This implies carvacrol has more antibacterial activity against S. mutans than thymol which agrees with the antibacterial activities of the chemotypes of EOs in the present study. The MIC/MBC values of thymol and carvacrol against S. mutans were 5 mg/mL/10 mg/mL and 2.5 mg/mL/5 mg/mL respectively [39]. In the present study, the MIC/ MBC doses were: Ofl, Ala, Yil, and Buta EOs (0.5/0.5 μl/mL) against both S. mutans and Lactobacillus and Bal EO (0.25/0.25) μl/mL against S. mutans and 0.5/0.5 μl/mL against Lactobacillus.

The present study shows that the EOs of T. serrulatus from Ala, Ofl, and Yil and T. schimperi from Tar, Buta, and Bal showed antimicrobial activity against cariogenic bacteria namely S. mutans and Lactobacillus. S. mutans and Lactobacillus have been tested for antimicrobial susceptibility to other EOs [39]. As far as known, this is the first report on the antibacterial activities of the EOs of T. serrulatus and T. schimperi against oral pathogenic bacteria.

Thyme EOs have been known to possess antibacterial properties for long [19], and the Gram-positive bacteria are generally susceptible to these EOs than the Gram-negative ones [14]. S. mutans and Lactobacillus both of which are Gram-positive bacteria thus were highly inhibited by the EOs of T. serrulatus and T. schimperi. The major components of thyme EOs result in antibacterial activities against cariogenic pathogens [39]. T.serrulates and T. schimperi found to be thymol (Ofl, Ala, Baland Tar) and carvacrol (Yil and Buta) chemotypes [25] in this study thus inhibited S. mutans and Lactobacillus. This agrees with other thyme EOs which have antiseptic effects when applied externally or taken internally [19]. This may be due to the lipophilic character of the hydrocarbon skeletons of the EO constituents as well as the hydrophilic character of their functional groups. The rank of activity of EO components is: phenols > aldehydes > ketones > alcohols > esters > hydrocarbons [23]. The findings in this research show that the major components of the EOs were phenols (thymol or carvacrol) [25]. Thus they had effective antibacterial activities against cariogenic bacteria. The antibacterial activity of these EOs may have resulted from the bioactivities of their major components or the interactions of all their components [40]. For example in a review of studies made by Bassolé & Juliani [41], thymol and carvacrol interactions majorly showed synergistic activities against pathogenic bacteria. Synergistic activities were also seen between combinations of Eos; thymol and eugenol, carvacrol and eugenol, carvacrol and linalool, menthol and geraniol, and menthol and thymol against different bacteria. The total antibacterial activities of EOs, in general, are due to the synergistic, additive, and antagonistic activities of their components.

The mechanism of action of the EOs of T. serrulatus and T. schimperi against S. mutans and Lactobacillus may be owing to their action on multiple targets of action [38]. Such sites of action include the ability to inhibit respiration [42, 43], increase the permeability of cytoplasmic and plasma membranes [43, 44], increased potassium ion leakage, increased disruption of the permeability barrier of cell membrane structures, as well as the loss of chemiosmotic control [42, 43]; disruption of polysaccharides, fatty acids, and phospholipids in different layers of these structures [44, 45]. Besides, EOs may cause coagulation of the cytoplasm and damage of lipids and proteins of microorganisms [44]. To sum up, the mode of action of EOs against these bacteria may be in the same way as broad-spectrum membrane-active disinfectants and preservatives, such as phenol derivatives, chlorhexidine, and para benzoic acid derivatives [46]. S. mutans and Lactobacillus were found to be sensitive to 3% H2O2. This is because of their incapacity to produce the enzyme catalase. Catalase converts H2O2 into harmless molecules, H2O, and molecular O2 [47].

Conclusion

The EOs of T. serrulatus and T. schimperi showed a high level of antibacterial activity against tooth decay bacteria, S. mutans, and Lactobacillus in a dose-dependent manner. The EOs from Tar with close proportions of thymol and carvacrol were the most effective EO followed by the carvacrol dominant EO of Yil and thymol dominant EOs with relatively lower antibacterial activity.

Supporting information

S1 Fig

Isolation of S. mutans (a) and Lactobacillus (b) colonies on MS and MRS agars respectively.

(DOCX)

S2 Fig

Results for Gram staining experiments on S. mutans (a) and Lactobacillus (b).

(DOCX)

S3 Fig

Sugar hydrolysis and arginine hydrolysis test results of S. mutans (a) and Lactobacillus (b).

(DOCX)

S4 Fig. The aerobic growth test result of S. mutans and Lactobacillus.

(DOCX)

S5 Fig. Inhibition of Lactobacillus by Ofl EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S6 Fig. Inhibition of S. mutans by Ofl EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S7 Fig. Inhibition of Lactobacillus by Ala EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S8 Fig. Inhibition of S. mutans by Ala EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S9 Fig. Inhibition of Lactobacillus by Yil EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S10 Fig. Inhibition of S. mutans by Yil EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S11 Fig. Inhibition of Lactobacillus by Tar EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S12 Fig. Inhibition of S. mutans by Tar EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S13 Fig. Inhibition of Lactobacillus by Buta EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S14 Fig. Inhibition of S. mutans by Buta EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S15 Fig. Inhibition of Lactobacillus by Bal EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S16 Fig. Inhibition of S. mutans by Bal EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

(DOCX)

S17 Fig

Inhibition of S. mutans (a) and Lactobacillus (b) by 3% DMSO.

(DOCX)

S18 Fig

Inhibition of S. mutans (a) and Lactobacillus (b) by 3% H2O2.

(DOCX)

S1 File. Ethical clearance letter.

(DOCX)

Acknowledgments

We would like to acknowledge the Ministry of Education of Ethiopia, Bahir Dar University, Addis Ababa University.

List of abbreviations

Ala

Essential Oil of thyme from Alamata

ANOVA

Analysis of Variance

Bal

Essential Oil of thyme from Bale

Buta

Essential Oil of thyme from Buta Jira

DMFT

Decayed, Missing and Filled Teeth

DMSO

dimethyl sulfoxide

EOs

Essential Oils

EUCAST

European Committee for Antimicrobial Susceptibility Testing

MBC

Minimum Bactericidal Concentration

MIC

Minimum Inhibitory Concentration

MRS agar

de Man, Rogosa and Sharpe agar

MS agar

Mitis Salivarius agar

Ofl

Essential Oil of thyme from Ofla

SPSS

Statistical Package for Social Sciences

Tar

Essential Oil of thyme from Tarmaber

Yil

Essential Oil of thyme from Yilmana Densa

Data Availability

All data generated or analyzed during this study except the chemical compositions of T. serrulatus and T. schimperi EOs are included within the manuscript and its supplementary information files. The chemical compositions of the EOs of these species are published in the Journal of Essential Oil Research as noted in the paper and References.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Gibbons R, Houte J. Dental caries. Annual review of medicine. 1975;26(1):121–36. [DOI] [PubMed] [Google Scholar]
  • 2.Pitts NB, Zero DT, Marsh PD, Ekstrand K, Weintraub JA, Ramos-Gomez F, et al. Dental caries. Nature Reviews Disease Primers. 2017;3(1):17030 10.1038/nrdp.2017.30 [DOI] [PubMed] [Google Scholar]
  • 3.Organization WH. Disease burden and mortality estimates: disease burden 2000–2016. 2020. [Google Scholar]
  • 4.Bagramian RA, Garcia-Godoy F, Volpe AR. The global increase in dental caries. A pending public health crisis. Am J Dent. 2009;22(1):3–8. [PubMed] [Google Scholar]
  • 5.Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiological Reviews. 1986;50(4):353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sinkiewicz G. Lactobacillus reuteri in Health and Disease: Malmö University; 2010. [Google Scholar]
  • 7.Lee Y. Diagnosis and prevention strategies for dental caries. Journal of lifestyle medicine. 2013;3(2):107 [PMC free article] [PubMed] [Google Scholar]
  • 8.Martínez-Mier EA. Fluoride: its metabolism, toxicity, and role in dental health. Journal of Evidence-Based Complementary & Alternative Medicine. 2012;17(1):28–32. [Google Scholar]
  • 9.Janakiram C, Venkitachalam R, Fontelo P, Iafolla TJ, Dye BA. Effectiveness of herbal oral care products in reducing dental plaque & gingivitis–a systematic review and meta-analysis. BMC complementary medicine and therapies. 2020;20(1):1–12. 10.1186/s12906-019-2780-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Singh K, Singh P, Oberoi G. Comparative studies between herbal toothpaste (dantkanti) and nonherbal Toothpaste. Int J Dent Res. 2016;4(2):53–6. [Google Scholar]
  • 11.Mehrgan H, Mojab F, Pakdaman S, Poursaeed M. Antibacterial activity of Thymus pubescens methanolic extract. Iranian Journal of Pharmaceutical Research. 2010;(4):291–5. [PubMed] [Google Scholar]
  • 12.Reichling J, Schnitzler P, Suschke U, Saller R. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties–an overview. Complementary Medicine Research. 2009;16(2):79–90. [DOI] [PubMed] [Google Scholar]
  • 13.Freires IA, Denny C, Benso B, De Alencar SM, Rosalen PL. Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: a systematic review. Molecules. 2015;20(4):7329–58. 10.3390/molecules20047329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Niculae M, Spînu M, Şandru CD, Brudaşcă F, Cadar D, Szakacs B, et al. Antimicrobial potential of some Lamiaceae essential oils against animal multiresistant bacteria. Lucrări Ştinłifice Medicină Veterinară. 2009;42(1):170–5. [Google Scholar]
  • 15.Demissew S, Asfaw N. Some useful indigenous labiates from Ethiopia. Lamiales Newsletter. 1994;3:5–6. [Google Scholar]
  • 16.Dagne E, Hailu S, Bisrat D, Worku T. Constituents of the essential oil of Thymus schimperi. Bulletin of the Chemical Society of Ethiopia. 1998;12(1):79–82. [Google Scholar]
  • 17.Bekele A, Abera R, Mebratu T, Dessie W, Getu A, Getnet B. Antimicrobial activity of Thymus schimperi Ronninger (Lamiaceae) against standard and clinical isolates of human pathogenic bacteria. Journal of Medicinal Plants Research. 2015;9(11):379–84. [Google Scholar]
  • 18.Nasir M, Tafess K, Abate D. Antimicrobial potential of the Ethiopian Thymus schimperi essential oil in comparison with others against certain fungal and bacterial species. BMC Complementary and Alternative Medicine. 2015;15(1):260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kaloustian J, Abou L, Mikail C, Amiot MJ, Portugal H. Southern French thyme oils: a chromatographic study of chemotypes. Journal of the Science of Food and Agriculture. 2005;85(14):2437–44. [Google Scholar]
  • 20.Zarchil M, Babaei A. An investigation of thyme effect on Helicobacter pylori. Middle East J Scientific Res. 2006;1:54–7. [Google Scholar]
  • 21.Azuma K, Ito H, Ippoushi K, Higashio H. In vitro antibacterial activity of extracts from four Labiatae herbs against Helicobacter pylori and Streptococcus mutans. Bulletin of the National Institute of Vegetable and Tea Science (Japan). 2003. [Google Scholar]
  • 22.Hussien J, Teshale C, Mohammed J. Assessment of the antimicrobial effects of some Ethiopian aromatic spice and herb hydrosols. Int J Pharmacol. 2011;7(5):635–40. [Google Scholar]
  • 23.Figueiredo A, Barroso J, Pedro L, Salgueiro L, Miguel MG, Faleiro M. Portuguese Thymbra and Thymus species volatiles: chemical composition and biological activities. Current Pharmaceutical Design. 2008;14(29):3120–40. 10.2174/138161208786404218 [DOI] [PubMed] [Google Scholar]
  • 24.Asfaw N, Storesund H, Skattebøl L, Tønnesen F, Aasen A. Volatile oil constituents of two Thymus species from Ethiopia. Flavour and Fragrance Journal. 2000;15(2):123–5. [Google Scholar]
  • 25.Damtie D, Braunberger C, Conrad J, Mekonnen Y, Beifuss U. Composition and hepatoprotective activity of essential oils from Ethiopian thyme species (Thymus serrulatus and Thymus schimperi). Journal of Essential Oil Research. 2019;31(2):120–8. [Google Scholar]
  • 26.Damtie D, Mekonnen Y. Thymus species in Ethiopia: distribution, medicinal value, economic benefit, current status, and threatening factors. Ethiopian Journal of Science and Technology. 2015;8(2):81–92. [Google Scholar]
  • 27.Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. The Journal of the American Dental Association. 2008;139:35S–40S. 10.14219/jada.archive.2008.0353 [DOI] [PubMed] [Google Scholar]
  • 28.Mac Faddin JF. Biochemical tests for identification of medical bacteria: Williams & Wilkins Co; 1976. [Google Scholar]
  • 29.Penmetsa RKR, Sri Rekha A, Poppuri KC, Sai Prashanth P, Garapati S. An in vitro evaluation of antibacterial properties of self-etching dental adhesive systems. Journal of clinical and diagnostic research: JCDR. 2014;8(7): ZC01 10.7860/JCDR/2014/9010.4467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Phankhongsap A, Chailertvanitkul P, Juntavee A, Peerapattana J, Puasiri S. Effectiveness of root canal irrigant from mangosteen pericarp extract with papain and propolis extracts with papain on the mixture of Streptococcus gordonii and Enterococcus faecalis. J dent Assoc Thai. 2014;64:234–42. [Google Scholar]
  • 31.Microbiology ECfASTotESoC, Diseases I. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clinical Microbiology and Infection. 2000;6(9):509–15. 10.1046/j.1469-0691.2000.00142.x [DOI] [PubMed] [Google Scholar]
  • 32.McGhie D, Hutchison J, Nye F, Ball A. Infective endocarditis caused by Streptococcus mutans. Heart. 1977;39(4):456–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bokhout B, Van Loveren C, Hofman FXW, Buijs JF, Van Limbeek J, Prahl-Andersen B. Prevalence of Streptococcus mutans and lactobacilli in 18-month-old children with cleft lip and/or palate. The Cleft palate-craniofacial journal. 1996;33(5):424–8. 10.1597/1545-1569_1996_033_0424_posmal_2.3.co_2 [DOI] [PubMed] [Google Scholar]
  • 34.Upadhyay RK, Dwivedi P, Ahmad S. Screening of antibacterial activity of six plant essential oils against pathogenic bacterial strains. Asian J Med Sci. 2010;2(3):152–8. [Google Scholar]
  • 35.Saokovic M, Mari P, Brikic D, Leo J. Chemical Composition and Antibacterial Activity of Essential Oils of Ten Aromatic Plants Against Human Pathogenic Bacteria. Food Global Science Books. 2007. [Google Scholar]
  • 36.Didry N, Dubreuil L, Pinkas M. Antibacterial activity of thymol, carvacrol and cinnamaldehyde alone or in combination. Die Pharmazie. 1993;48(4):301–4. [PubMed] [Google Scholar]
  • 37.Du E, Gan L, Li Z, Wang W, Liu D, Guo Y. In vitro antibacterial activity of thymol and carvacrol and their effects on broiler chickens challenged with Clostridium perfringens. Journal of animal science and biotechnology. 2015;6(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Barkat M, Bouguerra A. Study of the antifungal activity of essential oil extracted from seeds of Foeniculum vulgare Mill. for its use as food conservative. African Journal of Food Science. 2012;6(9):239–44. [Google Scholar]
  • 39.Botelho M, Nogueira N, Bastos G, Fonseca S, Lemos T, Matos F, et al. Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens. Brazilian Journal of Medical and Biological Research. 2007;40(3):349–56. 10.1590/s0100-879x2007000300010 [DOI] [PubMed] [Google Scholar]
  • 40.Zengin H, Baysal AH. Antibacterial and antioxidant activity of essential oil terpenes against pathogenic and spoilage-forming bacteria and cell structure-activity relationships evaluated by SEM microscopy. Molecules. 2014;19(11):17773–98. 10.3390/molecules191117773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bassolé IHN, Juliani HR. Essential oils in combination and their antimicrobial properties. Molecules. 2012;17(4):3989–4006. 10.3390/molecules17043989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Cox S, Mann C, Markham J, Bell HC, Gustafson J, Warmington J, et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). Journal of applied microbiology. 2000;88(1):170–5. 10.1046/j.1365-2672.2000.00943.x [DOI] [PubMed] [Google Scholar]
  • 43.Nazzaro F, Fratianni F, De Martino L, Coppola R, De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals. 2013;6(12):1451–74. 10.3390/ph6121451 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Tripathi M, Chawla P, Upadhyay R, Trivedi S. Essential oils from family Zingiberaceae for antimicrobial activity-a review. International Journal of Pharma and BioSciences. 2013;4(4). [Google Scholar]
  • 45.Abdul-Hafeez EY, Nguyen TN, Karamova NS, Ilinskaya ON. Antibacterial activity of certain medicinal plants on different bacterial strains associated with colorectal cancer. Int J Biosci. 2014;5(7):219–29. [Google Scholar]
  • 46.Montanari RM, Barbosa LC, Demuner AJ, Silva CJ, Carvalho LS, Andrade NJ. Chemical composition and antibacterial activity of essential oils from Verbenaceae species: Alternative sources of (E)-caryophyllene and germacrene-D. Química Nova. 2011;34(9):1550–5. [Google Scholar]
  • 47.Matés J. Perez-Gomez C, Nunez DE, Castro I. Antioxidant enzymes and human diseases Clin biochem. 1999;32(8):595–03. 10.1016/s0009-9120(99)00075-2 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Leonidas Matsakas

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

21 Jul 2020

PONE-D-20-17109

Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria

PLOS ONE

Dear Dr. Damtie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 04 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Leonidas Matsakas

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional location information of the collection sites, including geographic coordinates for the data set if available.

3. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the collection site access and, if no permits were required, a brief statement explaining why.

4. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population, e) a description of how participants were recruited, and f) descriptions of where participants were recruited and where the research took place.

5.Thank you for stating the following in the Funding Section of your manuscript:

[The Ministry of Education of Ethiopia, Addis Ababa University, and Bahirdar University funded this research work.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 [No]

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper “Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria” reports the antibacterial activities of the essential oils of Thymus serrulatus and Thymus schimperi collected from different areas of Ethiopia against cariogenic bacteria (Streptococcus mutans and Lactobacillus). The methodology is well described and the results are clearly discussed.

Some points should be clarified before publication:

- The introduction is too short and needs implementing. The other activities of Thymus and EOs in general could be discussed: see for example “Mediterranean essential oils as precious matrix components and active T ingredients of lipid nanoparticles, Int. J. Pharm. 548 (2018) 217–226”.

- Section “Plant material collection and identification”: thymus collected in Ofla is not reported, while it is mentioned in the abstract.

- Line 79: even though a reference was provided, a brief description of the procedure followed to collect saliva should be provided for the benefit of the reader.

Reviewer #2: 1. Essential oil production is not appropriate term. Its better to use professional terms.

2. "Aerial parts of T. serrulatus and T. schimperi collected from the wild ….. ". this sentence needs edition.

3. Please describe the process of dilution of essential oils and pouring them in the agar

4. "They too were not able to release gas from H2O2"

5. "The EOs doses ranging from 16 μl/mL to 128 μl/mL of Ala too showed" needs edition.

The text needs edition grammatically.

6. Its better to define exactly the terms in tables such as : Yil , Tar,Ala ,Buta and ….

7. The same subject is also persistent for the text.

8. "The EOs of thyme in the present study contained components with high antibacterial activities 250(thymol and carvacrol)". With which results, you claimed this in discussion ? please clarify the subject? Or refer to your another published work?

This subject is persistent for all of the discussion.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Shirin Moradkhani

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 9;15(10):e0239775. doi: 10.1371/journal.pone.0239775.r002

Author response to Decision Letter 0


28 Aug 2020

Comment 1: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response 1: Gone through and corrected

Comment 2: In your Methods section, please provide additional location information of the collection sites, including geographic coordinates for the data set if available.

Response 2: Added (Lines 84-87)

Comment 3: In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the collection site access and, if no permits were required, a brief statement explaining why.

Response 3: Plant materials were collected from the wild where every body used to collect them for local use. Thus, the researchers did not need permit to collect the plant materials. (Lines 90-92)

Comment 4: In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population, e) a description of how participants were recruited, and f) descriptions of where participants were recruited and where the research took place.

Response 4: The participants served only as sources of bacteria. The study was conducted on bacteria. The findings are generalized to bacteria not to sources of bacteria. What was required is Ethical clearance and it is attached with the supplementary materials.

Comment 5: Thank you for stating the following in the Funding Section of your manuscript:

[The Ministry of Education of Ethiopia, Addis Ababa University, and Bahirdar University funded this research work.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

[No]

Response 5: Edited as [No] (Line 383)

Reviewer 1

Comment 1:

• The introduction is too short and needs implementing. The other activities of Thymus and EOs in general could be discussed: see for example “Mediterranean essential oils as precious matrix components and active T ingredients of lipid nanoparticles, Int. J. Pharm. 548 (2018) 217–226”.

Response 1: Introduction is lengthened by addition of further information

- Lines 35-62

- Lines 66-59

Comment 2:

• Section “Plant material collection and identification”: thymus collected in Ofla is not reported, while it is mentioned in the abstract.

Response 2:

- Corrected (Line 84)

Comment 3:

• Line 79: even though a reference was provided, a brief description of the procedure followed to collect saliva should be provided for the benefit of the reader.

Response 3:

- Corrected (Lines 110-118)

Reviewer 2

Comment 1

- Essential oil production is not appropriate term. Its better to use professional terms.

Response 1

- Corrected as “Preparation of plant materials and extraction of essential oils” (Line 93)

Comment 2

- "Aerial parts of T. serrulatus and T. schimperi collected from the wild ….. ". This sentence needs edition.

Response 2

- Corrected as “The collected T. serrulatus and T. schimperi plants were shade dried and milled into powders.” (Lines 93-94)

Comment 3

- Please describe the process of dilution of essential oils and pouring them in the agar

Response 3

- Described in Lines 150-152

Comment 4

- "They too were not able to release gas from H2O2"

Response 4

- Modified as “They too were catalase negative” (Line 191)

Comment 5

- "The EOs doses ranging from 16 μl/mL to 128 μl/mL of Ala too showed" needs edition.

Response 5

- Modified as “In the same way, the EOs doses ranging from 16 μl/mL to 128 μl/mL of Ala showed considerable inhibition to this bacterium even though their zones of inhibition were less than that of the 3% H2O2” (Lines 213-215)

Comment 6

- Its better to define exactly the terms in tables such as : Yil , Tar,Ala ,Buta and ….

Response 6

- Corrected (Lines 232 & 278)

Comment 7

- "The EOs of thyme in the present study contained components with high antibacterial activities 250(thymol and carvacrol)". With which results, you claimed this in discussion ? please clarify the subject? Or refer to your another published work?

Response 7

- Corrected (Lines 79, 293, 295, 323, & 329)

Decision Letter 1

Leonidas Matsakas

1 Sep 2020

PONE-D-20-17109R1

Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria

PLOS ONE

Dear Dr. Damtie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Leonidas Matsakas

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Please address the following:

- Correct the references in the text that were added during the revising process.

- Remove the comments you have included.

- In L145 (the version with corrections indicated), change 'percentage' to '%', add units (i.e. v/v?) and specify specify to which solution was the 3% DMSO prepared.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 9;15(10):e0239775. doi: 10.1371/journal.pone.0239775.r004

Author response to Decision Letter 1


9 Sep 2020

� Correct the references in the text that were added during the revising process.

- The newly added references were; 6, 13, 17, 18, 25, 36, and 37. They are found in their correct forms.

� Remove the comments you have included.

- Removed.

� In L145 (the version with corrections indicated), change 'percentage' to '%', add units (i.e. v/v?) and specify specify to which solution was the 3% DMSO prepared.

- Corrected Line 150

- Line 153

Attachment

Submitted filename: Response.docx

Decision Letter 2

Leonidas Matsakas

14 Sep 2020

Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria

PONE-D-20-17109R2

Dear Dr. Damtie,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Leonidas Matsakas

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Leonidas Matsakas

29 Sep 2020

PONE-D-20-17109R2

Antibacterial activity of essential oils from Ethiopian thyme (Thymus serrulatus and Thymus schimperi) against tooth decay bacteria

Dear Dr. Damtie:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Leonidas Matsakas

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig

    Isolation of S. mutans (a) and Lactobacillus (b) colonies on MS and MRS agars respectively.

    (DOCX)

    S2 Fig

    Results for Gram staining experiments on S. mutans (a) and Lactobacillus (b).

    (DOCX)

    S3 Fig

    Sugar hydrolysis and arginine hydrolysis test results of S. mutans (a) and Lactobacillus (b).

    (DOCX)

    S4 Fig. The aerobic growth test result of S. mutans and Lactobacillus.

    (DOCX)

    S5 Fig. Inhibition of Lactobacillus by Ofl EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S6 Fig. Inhibition of S. mutans by Ofl EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S7 Fig. Inhibition of Lactobacillus by Ala EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S8 Fig. Inhibition of S. mutans by Ala EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S9 Fig. Inhibition of Lactobacillus by Yil EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S10 Fig. Inhibition of S. mutans by Yil EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S11 Fig. Inhibition of Lactobacillus by Tar EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S12 Fig. Inhibition of S. mutans by Tar EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S13 Fig. Inhibition of Lactobacillus by Buta EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S14 Fig. Inhibition of S. mutans by Buta EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S15 Fig. Inhibition of Lactobacillus by Bal EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S16 Fig. Inhibition of S. mutans by Bal EO (doses: 16μl/mL, 32μl/mL, 64μl/mL, and 128μl/mL respectively).

    (DOCX)

    S17 Fig

    Inhibition of S. mutans (a) and Lactobacillus (b) by 3% DMSO.

    (DOCX)

    S18 Fig

    Inhibition of S. mutans (a) and Lactobacillus (b) by 3% H2O2.

    (DOCX)

    S1 File. Ethical clearance letter.

    (DOCX)

    Attachment

    Submitted filename: Response.docx

    Data Availability Statement

    All data generated or analyzed during this study except the chemical compositions of T. serrulatus and T. schimperi EOs are included within the manuscript and its supplementary information files. The chemical compositions of the EOs of these species are published in the Journal of Essential Oil Research as noted in the paper and References.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES